These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 1890625

  • 21. Pharmacological characterization of the discriminative-stimulus effects of GBR 12909.
    Melia KF, Spealman RD.
    J Pharmacol Exp Ther; 1991 Aug; 258(2):626-32. PubMed ID: 1678014
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK, Platt DM, Yao WD, Spealman RD.
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [Abstract] [Full Text] [Related]

  • 28. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
    Kamien JB, Goldberg LI, Woolverton WL.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):804-11. PubMed ID: 2958620
    [Abstract] [Full Text] [Related]

  • 29. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S, Lee J, Kiguchi M, Uchida T, Cools AR, Waddington JL, Koshikawa N.
    Eur J Pharmacol; 2006 May 24; 538(1-3):94-100. PubMed ID: 16682023
    [Abstract] [Full Text] [Related]

  • 30. Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats.
    Bhargava HN, Gulati A.
    J Pharmacol Exp Ther; 1990 Mar 24; 252(3):901-7. PubMed ID: 2138669
    [Abstract] [Full Text] [Related]

  • 31. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
    Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1995 Feb 24; 117(4):403-12. PubMed ID: 7604140
    [Abstract] [Full Text] [Related]

  • 32. Interaction of haloperidol and SCH 23390 with cocaine and dopamine receptor subtype-selective agonists on schedule-controlled behavior of squirrel monkeys.
    Witkin JM, Schindler CW, Tella SR, Goldberg SR.
    Psychopharmacology (Berl); 1991 Feb 24; 104(4):425-31. PubMed ID: 1838199
    [Abstract] [Full Text] [Related]

  • 33. Behavioral effects of dopaminergic agonists and antagonists alone and in combination in the squirrel monkey.
    Katz JL, Witkin JM.
    Psychopharmacology (Berl); 1993 Feb 24; 113(1):19-25. PubMed ID: 7862823
    [Abstract] [Full Text] [Related]

  • 34. L-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses.
    Paalzow GH.
    J Pharmacol Exp Ther; 1992 Nov 24; 263(2):470-9. PubMed ID: 1432683
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Interactions between cocaine and dopamine agonists on cardiovascular function in squirrel monkeys.
    Schindler CW, Gilman JP, Bergman J, Mello NK, Woosley RL, Goldberg SR.
    J Pharmacol Exp Ther; 2002 Jan 24; 300(1):180-7. PubMed ID: 11752114
    [Abstract] [Full Text] [Related]

  • 37. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys.
    Desai RI, Neumeyer JL, Paronis CA, Nguyen P, Bergman J.
    Eur J Pharmacol; 2007 Mar 08; 558(1-3):98-106. PubMed ID: 17207791
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
    Westlind-Danielsson A, Gustafsson K, Andersson I.
    Eur J Pharmacol; 1994 Dec 15; 288(1):89-95. PubMed ID: 7705472
    [Abstract] [Full Text] [Related]

  • 40. Neuroleptics cause stimulation of dopamine D1 receptors and their desensitization after chronic treatment.
    Imperato A, Obinu MC, Carta G, Mascia MS, Casu MA, Dazzi L, Gessa GL.
    Eur J Pharmacol; 1994 Oct 13; 264(1):55-60. PubMed ID: 7828643
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.